|
Population | Study design | Sample size | Phenotype | Allele, genotype, or haplotype | Type of association | P | Ref. |
|
Brazilian | Case-control | 70LL, 85BL, 55BB, 2BT, 63TT, 10IL, 15 pure neural, 92 controls | BT/TT | TNF-308A | Resistance | | [43] |
|
Brazilian | Case-control | 74BT | BT/TT | TNF-308A | Resistance | ND | [44] |
|
Brazilian | Case-control | 210MB, 90PB, 92 controls 143MB, 79PB, 62 controls | LD PB LD | TNF-308A IL10-819T IL10-819TT | Resistance Susceptibility Susceptibility |
| [45] |
|
Brazilian | Case-control | 43TT, 65LL, 50BB, 9IL, 240 controls | LD LL | TNF-308A IL10-1082G/-819C/-592C | Resistance Resistance |
| [46] |
|
Brazilian | Family study case-control | 363LD 1146LD, 1036 controls | LD | TNF-308A | Resistance Resistance |
| [47] |
|
Nepal | Case-control | 581(LL,BL,BB), 343(BT,TT); 101 controls | LD | TNF-308A | Resistance | | [48] |
|
Indian | Case-control | 121LL, 107TT, 160 controls | LL | TNF-308A | Susceptibility | | [49] |
|
Thai | Case-control | 24MB, 13PB, 140 controls | MB LD | TNF-308A TNF-308GA | Susceptibility Susceptibility |
| [50] |
|
French Polynesian | Family study | 6 families | LD | IL-1 beta, TNF-alpha (1, 2), and TNF-alpha (A, G) | ns | | [51] |
|
Brazilian | Multi case families study | 76 families | LD | TNF
*
1 TNF*1/LTA*2 TNF*2/LTA*2 | Susceptibility Susceptibility Resistance |
| [31] |
|
Mexican | Case-control | 62 cases, 144 controls | LL | TNF-308G/A IL10-819C | ns | | [52] |
|
Indian | Case-control | 449PB, 473MB, 1670 controls | LD | BAT1-LTA-TNF-BTNL2 | Susceptibility | | [53] |
|
Brazilian | Case-control Meta-analysis | 374 cases, 380 controls 2702 individuals (5 studies) | LD | IL10-819T | Susceptibility | | [54] |
|
Colombian | Case-control | 100 cases, 100 controls | LD | IL10-819CC and CT IL10-592CC and CA IL10-819C-592C IL10-1082A-819C-592C | Susceptibility Susceptibility Susceptibility Susceptibility |
| [55] |
|
Brazilian | Case-control | 131PB, 166MB, 283 controls | LD | IL10-3575A/-2849G/-2763C IL10-3575T/-2849A/2763C | Resistance Susceptibility |
| [56] |
|
Indian | Case-control | 144MB, 142PB, 266 controls | LD | IL10-3575T/-2849G/-2763C/-1082A/-819C/-592C IL10-3575T/-2849G/-2763C/-1082A/-819T/-592A | Resistance Susceptibility |
| [57] |
|
Indian | Case-control | 80 cases, 89 controls | LD | IL12B 3
′
UTR 2.2 | Resistance | | [58] |
|
Korean | Case-control | 93LL, 94 controls | LL | IL12RB1 IFNGR1 | ns | | [59] |
|
Japanese | Case-control | 130LL, 46TL, 68 controls | LL | IL12RB2-1035G IL12RB2-1023G IL12RB2-650delG IL12RB2-464G IL12RB2-1035A/-1023A/-650G/-464A | Susceptibility |
| [60]
|
|
Mexican | Case-control | 44LL, 51 controls | LL | IL12 3
′
UTR 1188A/C | Susceptibility | | [61] |
|
Mexican | Case-control | 66LL, 140 controls | LL | IL12 3
′
UTR 1188A/C | ns | | [62] |
|
Chinese | Multiple-stage genetic association | 4971 cases, 5503 controls | LD | IL18RAP/IL18R1(rs2058660) IL12B(rs6871626) | Susceptibility |
| [63] |
|
Brazilian | Case-control | 1045 cases, 1080 controls | LD | IFNG+ 874T | Resistance | | [64] |
|
Chinese | Case-control | 527 cases, 583 controls | LD LD, MB MB MB PB | IFNG+ 874T/A IFNG(10CA), IFNG(13CA) IFNG(15CA) IFNG(17CA) | ns Susceptibility Susceptibility Susceptibility Susceptibility |
| [65] |
|
Brazilian | Case-control | 108 cases, 113 controls | PB | IFNG+874AA IFNG(16CA) | Susceptibility Susceptibility |
| [66] |
|
Brazilian | Case-control | 10TT, 59BB, 27LL, 98 controls | LD | IFNG(15CA), (16CA), and (17CA) | Susceptibility | | [67] |
|
Iranian | Case report | 3 cases | LD | IFNGR1-56T/C | Susceptibility | ND | [68] |
|
Chinese | Case-control | 80PB, 352MB, 465 controls | LD | IL4-590TC IL4-590CC IL4-590C | Resistance Resistance Resistance |
| [69] |
|
Indian | Case-control | 2447 cases, 1294 controls | LD | IL-10 (rs1800871, rs1800872, rs1554286); IL-10RB (rs3171425; rs7281762); TGFBR2 (rs2228048, rs744751); IL-6 (rs1800797) | Susceptibility | | [70] |
|